CLINICAL_TRIALS
trial_result
· 2020-03-11
Clinical Trial Update: Pasireotide in Prevention of GI Toxicity [Phase 2]
Summary
Phase 2 clinical trial evaluating pasireotide for prevention of GI toxicity in hematological malignancies has completed with posted results in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Anthony Sung, MD | Conditions: Hematological Malignancies | Phase 2 | Status: COMPLETED | Results posted: 2020-03-11